Reena Aggarwal

CIK 1519118 · View on SEC EDGAR ↗

Insider

First SEC filing: June 2, 2017 · Latest: June 2, 2017

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 47 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

47 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
July 1, 2026	CNS	A	353	—	—	17,414 Direct	+2.07%	Acquired	(price as of 2026-08-20)
July 1, 2025	CNS	A	360	—	—	15,762 Direct	+2.34%	Acquired	(price as of 2026-08-20)
April 1, 2025	CNS	A	341	—	—	15,402 Direct	+2.26%	Acquired	(price as of 2026-08-20)
Jan. 2, 2025	CNS	A	298	—	—	15,061 Direct	+2.02%	Acquired	(price as of 2026-08-20)
Oct. 1, 2024	CNS	A	291	—	—	14,763 Direct	+2.01%	Acquired	(price as of 2026-08-20)
July 1, 2024	CNS	A	383	—	—	14,472 Direct	+2.72%	Acquired	(price as of 2026-08-20)
April 1, 2024	CNS	A	362	—	—	14,089 Direct	+2.64%	Acquired	(price as of 2026-08-20)
Jan. 5, 2024	NCDL	P	1,741	$18.05	$31,425	10,729 Indirect	+19.37%	Acquired	-31.4% (price as of 2026-08-20)
Jan. 2, 2024	CNS	A	365	—	—	13,727 Direct	+2.73%	Acquired	(price as of 2026-08-20)
Nov. 3, 2023	NCDL	P	1,213	$18.19	$22,064	8,988 Indirect	+15.60%	Acquired	-31.9% (price as of 2026-08-20)
Oct. 2, 2023	CNS	A	442	—	—	13,362 Direct	+3.42%	Acquired	(price as of 2026-08-20)
July 3, 2023	CNS	A	472	—	—	12,920 Direct	+3.79%	Acquired	(price as of 2026-08-20)
April 3, 2023	CNS	A	433	—	—	12,448 Direct	+3.60%	Acquired	(price as of 2026-08-20)
Jan. 3, 2023	CNS	A	419	—	—	12,015 Direct	+3.61%	Acquired	(price as of 2026-08-20)
Oct. 3, 2022	CNS	A	432	—	—	11,596 Direct	+3.87%	Acquired	(price as of 2026-08-20)
July 1, 2022	CNS	A	429	—	—	11,164 Direct	+4.00%	Acquired	(price as of 2026-08-20)
April 1, 2022	CNS	A	315	—	—	10,735 Direct	+3.02%	Acquired	(price as of 2026-08-20)
Jan. 21, 2022	NCDL	P	128	$19.46	$2,491	7,775 Indirect	+1.67%	Acquired	-36.4% (price as of 2026-08-20)
Jan. 3, 2022	CNS	A	298	—	—	10,420 Direct	+2.94%	Acquired	(price as of 2026-08-20)
Dec. 10, 2021	NCDL	P	436	$19.58	$8,537	7,647 Indirect	+6.05%	Acquired	-36.8% (price as of 2026-08-20)
Nov. 1, 2021	NCDL	P	305	$19.40	$5,917	7,211 Indirect	+4.42%	Acquired	-36.2% (price as of 2026-08-20)
Oct. 1, 2021	CNS	A	325	—	—	10,122 Direct	+3.32%	Acquired	(price as of 2026-08-20)
Aug. 24, 2021	NCDL	P	612	$19.28	$11,799	6,906 Indirect	+9.72%	Acquired	-35.8% (price as of 2026-08-20)
July 1, 2021	CNS	A	304	—	—	9,797 Direct	+3.20%	Acquired	(price as of 2026-08-20)
April 1, 2021	CNS	A	375	—	—	9,493 Direct	+4.11%	Acquired	(price as of 2026-08-20)
Jan. 4, 2021	CNS	A	341	—	—	9,118 Direct	+3.89%	Acquired	(price as of 2026-08-20)
Nov. 6, 2020	NCDL	P	6,294	$18.71	$117,761	6,294 Indirect	—	Acquired	-33.8% (price as of 2026-08-20)
Oct. 1, 2020	CNS	A	447	—	—	8,777 Direct	+5.37%	Acquired	(price as of 2026-08-20)
July 1, 2020	CNS	A	366	—	—	8,330 Direct	+4.60%	Acquired	(price as of 2026-08-20)
April 1, 2020	CNS	A	581	—	—	7,964 Direct	+7.87%	Acquired	(price as of 2026-08-20)
Jan. 2, 2020	CNS	A	395	—	—	7,383 Direct	+5.65%	Acquired	(price as of 2026-08-20)
Oct. 1, 2019	CNS	A	458	—	—	6,988 Direct	+7.01%	Acquired	(price as of 2026-08-20)
July 1, 2019	CNS	A	484	—	—	6,530 Direct	+8.01%	Acquired	(price as of 2026-08-20)
April 1, 2019	CNS	A	584	—	—	6,046 Direct	+10.69%	Acquired	(price as of 2026-08-20)
Jan. 2, 2019	CNS	A	732	—	—	5,462 Direct	+15.48%	Acquired	(price as of 2026-08-20)
Oct. 1, 2018	CNS	A	612	—	—	4,730 Direct	+14.86%	Acquired	(price as of 2026-08-20)
July 2, 2018	CNS	A	602	—	—	4,118 Direct	+17.12%	Acquired	(price as of 2026-08-20)
April 2, 2018	CNS	A	622	—	—	3,516 Direct	+21.49%	Acquired	(price as of 2026-08-20)
Jan. 2, 2018	CNS	A	528	—	—	2,894 Direct	+22.32%	Acquired	(price as of 2026-08-20)
Oct. 2, 2017	CNS	A	633	—	—	2,366 Direct	+36.53%	Acquired	(price as of 2026-08-20)
July 3, 2017	CNS	A	610	—	—	1,733 Direct	+54.32%	Acquired	(price as of 2026-08-20)
June 1, 2017	1371446	D	27,248	—	—	0 Direct	-100.00%	Disposed
April 3, 2017	CNS	A	633	—	—	1,123 Direct	+129.18%	Acquired	(price as of 2026-08-20)
Jan. 3, 2017	CNS	A	490	—	—	490 Direct	—	Acquired	(price as of 2026-08-20)
June 17, 2016	1371446	A	4,208	—	—	27,248 Direct	+18.26%	Acquired
Feb. 22, 2016	1371446	P	2,000	$15.92	$31,840	23,040 Direct	+9.51%	Acquired
June 16, 2015	1371446	A	2,993	—	—	21,040 Direct	+16.58%	Acquired
June 3, 2014	1371446	A	2,577	—	—	18,047 Direct	+16.66%	Acquired
May 27, 2014	1371446	M	10,504	—	—	0 Direct	—	Acquired
May 27, 2014	1371446	F	5,378	$26.32	$141,549	15,470 Direct	-25.80%	Disposed
May 27, 2014	1371446	S	416	$26.50	$11,024	20,848 Direct	-1.96%	Disposed
May 27, 2014	1371446	M	10,504	$14.52	$152,518	21,264 Direct	+97.62%	Acquired
June 5, 2012	1371446	A	2,786	—	—	10,760 Direct	+34.94%	Acquired
June 5, 2012	1371446	A	21,898	—	—	31,898 Direct	+218.98%	Acquired
June 1, 2011	1371446	A	42,016	—	—	42,016 Direct	—	Acquired
June 1, 2011	1371446	A	10,000	—	—	10,000 Direct	—	Acquired

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
May 27, 2014	1371446	Stock Option (right to buy)	Common Stock (10,504)	$14.52	June 1, 2015	10,504	Acquired
June 1, 2011	1371446	Stock Option (right to buy)	Common Stock (42,016)	$3.63	June 1, 2015	42,016	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).